Search results for "Fen"

showing 10 items of 3710 documents

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 …

2020

Our aim was to evaluate the association between recent eGFR values and risk of switching from TDF to TAF or dual therapy (DT) in real life. HIV-positive patients achieving HIV-RNA ≤50 copies/mL for the first time after starting a TDF-based regimen were included. Kaplan–Meier (KM) curves and Cox regression models were used to estimate the time from TDF to switch to TAF or DT. 1486 participants were included: median (IQR) age 36 (30–42) years; baseline CKD-EPI eGFR 99.92 (86.47–111.4) mL/min/1.73m2. We observed a consistently higher proportion of people with HIV-RNA ≤50 copies/mL who switched from TDF to TAF rather than to DT. By competing risk analysis, at 2 years from baseline, the probabil…

AdultMale0301 basic medicineMicrobiology (medical)Dual therapymedicine.medical_specialtyTenofovirAnti-HIV Agents030106 microbiologyUrologyRenal functionTenofovir alafenamide03 medical and health sciences0302 clinical medicineHiv infectedeGFRmedicineHumansPharmacology (medical)Prospective StudiesTenofovir alafenamide030212 general & internal medicineDual therapyTenofovirAcquired Immunodeficiency SyndromeAlanineDrug SubstitutionProportional hazards modelbusiness.industryAdenineHIVGeneral MedicineViral LoadAntiretroviral therapyRegimenInfectious DiseasesHIV-1Drug Therapy CombinationFemaleTenofovir disoproxil fumarate.businessViral loadGlomerular Filtration Ratemedicine.drugInternational Journal of Antimicrobial Agents
researchProduct

A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer

2021

Aim: To determine a recommended Phase II dose of the oral fluoropyrimidine trifluridine/tipiracil (FTD/TPI) combined with the multi-kinase inhibitor regorafenib (REG) in refractory metastatic colorectal cancer patients. Materials & methods: A conventional 3 + 3 dose finding design was used. FTD/TPI was administered on days 1–5 and 8–12 of a 28-day cycle, REG on days 2–22. Two dose levels were used: FTD/TPI 25 mg/m2 b.i.d. + REG 120 mg/d, then escalated to FTD/TPI 35 mg/m2 b.i.d. + REG 120 mg/d. Results: In total, 12 patients were treated at two dose levels. Three dose-limiting toxicities were observed; all were grade 3 hypertension causally attributed to REG. Recommended Phase II dose …

AdultMale0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyPyrrolidinesMaximum Tolerated DosePyridinesColorectal cancerAdministration OralTrifluridineDrug Administration ScheduleTrifluridine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRefractoryRegorafenibInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineDose escalationHumansResponse Evaluation Criteria in Solid TumorsAgedTipiracilDose-Response Relationship Drugbusiness.industryPhenylurea CompoundsGeneral MedicineMiddle Agedmedicine.diseaseProgression-Free SurvivalDrug Combinations030104 developmental biologyOncologychemistryThird lineDrug Resistance Neoplasm030220 oncology & carcinogenesisHypertensionToxicityFeasibility StudiesFemaleColorectal NeoplasmsbusinessThyminemedicine.drugFuture Oncology
researchProduct

Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetes

2016

AbstractRecent studies have shown that pharmacological increases in HDL cholesterol concentrations do not necessarily translate into clinical benefits for patients, raising concerns about its predictive value for cardiovascular events. Here we hypothesize that the size-modulated lipid distribution within HDL particles is compromised in metabolic disorders that have abnormal HDL particle sizes, such as type 2 diabetes mellitus (DM2). By using NMR spectroscopy combined with a biochemical volumetric model we determined the size and spatial lipid distribution of HDL subclasses in a cohort of 26 controls and 29 DM2 patients before and after two drug treatments, one with niacin plus laropiprant a…

AdultMale0301 basic medicineSimvastatinmedicine.medical_specialtyIndolesMagnetic Resonance SpectroscopySurface Properties030204 cardiovascular system & hematologyMicroscopy Atomic ForceNiacinArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFenofibrateInternal medicinemedicineHumansTriglyceridesAgedFluorescent DyesMultidisciplinaryFenofibrateCholesterolCholesterol HDLType 2 Diabetes Mellitusnutritional and metabolic diseasesLipid metabolismMiddle AgedLipid MetabolismLipids030104 developmental biologyEndocrinologyDiabetes Mellitus Type 2chemistryBiochemistryCardiovascular DiseasesSimvastatinFemalelipids (amino acids peptides and proteins)LaropiprantNiacinLipoproteinmedicine.drug
researchProduct

Development and Psychometric Properties of the Detection of Sexual Abuse Risk Screening Scale (DSARss).

2019

People with intellectual disability (ID) are more vulnerable to being victims of sexual abuse (SA) because, in most cases, they are not able to detect the warning signs that abuse could occur. However, there is a lack of appropriate assessment tools to determine their vulnerability. To address this limitation, the current study tests the psychometric properties of the Detection of Sexual Abuse Risk Screening Scale (DSARss), a new scale developed to assess the ability of individuals with mild or moderate ID to detect the risk of SA. In all, 246 individuals with mild or moderate ID (55.3% males) completed the DSARss, along with other scales assessing related dimensions (e.g., psychopathologi…

AdultMale030506 rehabilitationPsychometricsVulnerabilitysexual abusepsychometric propertiesSeverity of Illness Index03 medical and health sciencesDisability EvaluationIntellectual DisabilitySurveys and QuestionnairesIntellectual disabilitymedicineHumans0501 psychology and cognitive sciencesGeneral PsychologyCrime Victims05 social sciencesSex Offensesrisk assessmentReproducibility of ResultsMiddle Agedmedicine.diseaseExploratory factor analysisPsychiatry and Mental healthRisk screeningSexual abuseintellectual disabilityScale (social sciences)Female0305 other medical scienceRisk assessmentPsychology050104 developmental & child psychologyClinical psychologyPsychopathologySexual abuse : a journal of research and treatment
researchProduct

Criminological differences between child pornography offenders arrested in Spain.

2019

Abstract Background Lack of studies on CP offenders from non-English speaking countries motivated the analysis of the profile of adult men arrested in Spain for such crimes (N = 347). Objective The current study examined differences between groups of CP users according to their criminal history (i.e., CP-only offenders, CP offenders with other nonviolent or non-sexually violent crimes, and dual offenders). Methods Analyses of case investigation files were performed across seven key areas: (1) sociodemographic characteristics, (2) criminological data, (3) characteristics of index CP offending, (4) characteristics of CP collections, (5) access to children, (6) indication of pedophilic or hebe…

AdultMale050103 clinical psychologyAdolescentSexual BehaviorPoison controlSuicide preventionYoung AdultInjury preventionDevelopmental and Educational PsychologyEroticaHumans0501 psychology and cognitive sciencesChildPedophiliaAgedRecidivism05 social sciencesSex OffensesAge FactorsHuman factors and ergonomicsChild Abuse SexualCriminalsMiddle AgedPsychiatry and Mental healthRecidivismSocioeconomic FactorsChild pornographySpainChild sexual abusePediatrics Perinatology and Child HealthResidenceFemalePsychology050104 developmental & child psychologyClinical psychologyChild abuseneglect
researchProduct

The Importance of Considering Alexithymia during Initial Stages of Intimate Partner Violence Interventions to Design Adjuvant Treatments

2019

Empirical evidence supports that individuals with alexithymia might be prone to certain types of violence, such as intimate partner violence against women (IPVAW). Moreover, considering that alexithymia is directly involved in behavior regulation, problems due to identifying and regulating emotional states might be postulated as responsible, at least in part, for the success of psychotherapeutic treatments designed for decreasing the future risk of reoffending. Therefore, we assessed whether alexithymia was a good predictor of the discontinuation of treatment (dropout) and the risk of recidivism during the initial stages of intervention in a sample of men convicted of IPVAW perpetration (n …

AdultMale050103 clinical psychologydrug misuseHealth Toxicology and MutagenesisEmotionsPsychological interventionPoison controlIntimate Partner Violencelcsh:MedicineImpulsivitydropoutArticle03 medical and health sciences0302 clinical medicineAlexithymiaInjury preventionmedicineHumans0501 psychology and cognitive sciencesAffective Symptomsintimate partner violence against womenRecidivism05 social scienceslcsh:RPublic Health Environmental and Occupational HealthreoffendingHuman factors and ergonomicsMiddle AgedDones maltractadesmedicine.diseaseSocioeconomic FactorsDomestic violencemedicine.symptomDroguesalexithymiaPsychology030217 neurology & neurosurgeryClinical psychologyInternational Journal of Environmental Research and Public Health
researchProduct

The Prevalence of Sexual Violence: Results From a Population-Based Sample

2016

BACKGROUND: Sexual violence can cause severe mental and bodily harm. This is the first study of a population-based sample in Germany to assess both the frequency of the subjects' having experienced sexual violence and the frequency of their having manifested sexually aggressive behavior themselves. METHODS: 2513 persons (of whom 2422 were over age 18 and 91 were aged 14 to 18) were asked about their experiences with sexual violence in the past 12 months, either as the person committing sexual violence or as the victim of sexual violence at the hands of other adults or similarly aged adolescents. RESULTS: 0.6% (n = 6) of the men and 1.2% (n = 16) of the women surveyed, and ca. 5% (n = 4) of …

AdultMale050103 clinical psychologymedicine.medical_specialtyAdolescentPopulationPoison control050109 social psychologySuicide preventionOccupational safety and healthYoung AdultAge DistributionRisk FactorsGermanyInjury preventionPrevalenceHumansMedicine0501 psychology and cognitive sciencesSex DistributionPsychiatryeducationCrime VictimsAgedAged 80 and overeducation.field_of_studySexual violencebusiness.industrySex Offenses05 social sciencesHuman factors and ergonomicsGeneral MedicineMiddle AgedCrime statisticsOriginal ArticleFemalebusinessClinical psychologyDeutsches Ärzteblatt international
researchProduct

Technical, tactical and movement analysis of men's professional tennis on hard courts.

2018

Background There is very little information in tennis relating performance to both the movement of the players and the effectiveness of their shots. This study aimed to identify differences between winners and losers in the volume and intensity of their movements, as well as in the effectiveness of their shots. Methods Matches (N.=8) at the 2011 ATP 500 tournament in Valencia (Spain) were recorded and analyzed using SAGIT, a computerized vision-tracking system. Data were split into points for movement analysis, and into games for stroke analysis. Results Players winning points used more offensive strategies and spent more time in the offensive zone than point losers. They also forced point …

AdultMale060101 anthropologyMovementComputingMilieux_PERSONALCOMPUTINGOffensivePhysical Therapy Sports Therapy and RehabilitationAdvertising030229 sport sciences06 humanities and the artsAthletic PerformanceMovement analysis03 medical and health sciencesYoung Adult0302 clinical medicineSpainTennisHumans0601 history and archaeologyOrthopedics and Sports MedicineTournamentSports and Recreational FacilitiesPsychologyThe Journal of sports medicine and physical fitness
researchProduct

The Endogenous Opioid System Is Not Involved in Modulation of Opioid-Induced Hyperalgesia

2009

Abstract Some recent studies suggested a role of the endogenous opioid system in modulating opioid-induced hyperalgesia (OIH). In order to test this hypothesis, we conducted a prospective randomized, placebo-controlled, 2-way crossover study in healthy human volunteers. We utilized a well-established model of inducing OIH after a brief exposure to the μ-opioid agonist remifentanil using intradermal electrical stimulation. Patients were exposed to a randomized 90-minute infusion of remifentanil or saline placebo during 2 separate occasions. Development of OIH was quantified using changes in the average radius of the area of secondary hyperalgesia generated by electrical pain stimulation. A 2…

AdultMaleAgonistmedicine.drug_classNarcotic AntagonistsRemifentanilBlood PressureStimulationPharmacologyPlaceboRemifentanilYoung AdultDouble-Blind MethodPiperidinesHeart RatemedicineHumansOpioid-induced hyperalgesiaPain MeasurementEndogenous opioidCross-Over StudiesNaloxonebusiness.industryMiddle AgedAnalgesics OpioidAnesthesiology and Pain MedicineNeurologyOpioidHyperalgesiaAnesthesiaHyperalgesiaNeurology (clinical)medicine.symptombusinessmedicine.drugThe Journal of Pain
researchProduct

Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain d…

2011

Abstract Context Cancer patients receiving high doses of opioids as background medication are challenging, and it would be useful clinically to know whether a rapid-onset opioid (ROO) for breakthrough cancer pain (BTcP) may be started at a dose proportional to the background opioid dose. Objectives The aim of this study was to assess the efficacy and safety of the fentanyl buccal tablet (FBT) in doses proportional to the opioid dose administered for background analgesia in a sample of patients with BTcP who were receiving high doses of opioids. Methods Twelve patients who were receiving opioids for background analgesia at doses equivalent to more than 500 mg of oral morphine and had adequat…

AdultMaleBreakthrough PainContext (language use)Settore MED/42 - Igiene Generale E ApplicataFentanylNeoplasmsHumansMedicineAdverse effectGeneral NursingAgedPain MeasurementDose-Response Relationship Drugbusiness.industryBreakthrough PainAdministration BuccalCancerclinical trialBuccal administrationMiddle Agedmedicine.diseaseFentanyl buccal tabletbreakthrough pain cancer patientAnalgesics OpioidFentanylTreatment OutcomeAnesthesiology and Pain MedicineOpioidAnesthesiaFemaleNeurology (clinical)businessCancer painmedicine.drug
researchProduct